Host an Educational Program

Satellite Symposia provide your organization with a unique opportunity to host educational programs before or after DDW scientific sessions, often offering CME credit to participants. A limited number of symposia will be permitted so be sure to reserve yours today. Please note that DDW Council policy prohibits Satellite Symposia during scheduled scientific sessions.

There is no application deadline; however, slots are assigned based on receipt of payment. We can accept applications until all the slots are full. However, in order for your symposium to be included in the digital materials, your application and session details must be provided by March 17, 2023.

Symposia 2022 are available to view on demand through our virtual platform.

Guidelines

A limited number of satellite symposia will be permitted at DDW 2023.  This number is driven by hotel meeting space availability, which may vary in each city. Please keep in mind DDW hosts over 300+ In-Conjunction With meetings in addition to symposia only at our contracted hotel locations. The DDW Council prohibits symposia during scheduled scientific sessions. Symposia, or any portion of them, including registration and question-and-answer sessions, may only be held prior to 7:45 a.m. or after 6 p.m. during the designated timeslots. This policy will be strictly enforced, and any violations will result in loss of priority points earned for DDW 2023 if the symposium is hosted or supported by a current showcase supporter. If the symposium is not affiliated with a current industry supporter, DDW will determine the appropriate action, which is not limited to expulsion from participating in future DDW events. 

  • Space will be assigned by DDW on a first come, first served basis, based on hotel availability and when payment is received. Your symposium will not be placed until DDW has received full payment, regardless of your application date.
  • Symposia can be placed in any of the official DDW hotels based on meeting space availability. Altering your meeting specifications can result in movement of your symposia to another hotel location. Meeting space reservations are not exclusive to symposia.
  • Meeting space locations can be subject to food and beverage minimums, space rental, audio visual and equipment rental fees that is the responsibility of the symposia host. The symposia fee paid to DDW does not include these additional fees.
  • Space assignments are final and may not be switches unless done so by DDW.

  • Symposia dates are May 6-9, 2023. Only morning and evening slots are available. Morning symposia must end by 7:45 a.m., including question-and-answer periods. Evening symposia cannot start before 6 p.m. The duration of the symposium is up to the sponsoring company to arrange. 
  • Dates and times submitted on the application are just preferences. DDW will confirm your final date and time once full payment has been received based on availability. 
  • All confirmed dates and times are final and may not be switched unless done so by DDW. 

Available Dates and Times:

DatesMorning SlotsEvening Slots
Fri, May 5N/ACall for information
Sat, May 626
Sun, May 726
Mon, May 826
Tues, May 92N/A

The fee for one morning slot is $50,000, and the fee for one evening slot is $55,000. Please see the list below for additional information.

Morning symposium$50,000
Evening symposium$55,000
Two morning symposia$75,000
Two evening symposia$85,000
Morning and evening symposia$80,000
Morning symposium (non-exhibitor)$57,500
Evening symposium (non-exhibitor)$62,500
  • Assign appropriate space, day, time and provide the appropriate hotel contacts.
  • Provide one complimentary pre-registrant mailing list for use to promote the symposium. Subsequent lists are discounted 50% from the regular fee. Pre-registration list will be exported from the registration database. DDW is not responsible for list clean up or integrity of this list. List will be supplied by request.
  • DDW will send one combined email blast to attendees about two weeks prior to the convention.
  • DDW will provide two complimentary attendee badges (per symposium) to non-ticketed DDW scientific sessions.
  • Symposium listing on the DDW website, mobile application, and virtual platform.
  • If you wish to have a hybrid or virtual component for your Satellite Symposium, it is your responsibility to coordinate. DDW will place a listing within the online platform and on DDW.org. Supporters will be responsible for providing the link to the hybrid or virtual symposium or recording. Link to your virtual meeting room, website or recording will be due to DDW by April 15, 2023.If you record your on-site or virtual Satellite Symposium, DDW will host your recording on DDW.org through Aug. 31, 2023. More information will be provided once a contract is submitted.

For marketing opportunities for Satellite Symposia, please email industry@ddw.org.

Pre-Meeting 

  • DDW reserves the right to review all symposium applications and promotional materials and to reject topics, formats or materials deemed inappropriate.  
  • Program content must be relevant to digestive health or GI practice.  
  • Approval from DDW does not constitute an endorsement of the program or its contents by DDW or its partnering societies. 

Printed and Published Materials 

  • All industry sponsors/supporters must be listed on all printed and published materials.  
  • All printed and published materials must bear the following information: Sponsored by…, Supported by…, and coordinated by…  
  • All advertisements, promotions or invitations for the symposium must bear the following statement: “This program is not affiliated with Digestive Disease Week®.” This statement must appear on the cover/front page of any copy using at least a 12-pt. font size.  
  • The DDW logo and the Digestive Disease Week® (or DDW®) name may not be used in any promotions, advertisements, meeting materials or correspondence related to the program.

Payment Terms 

All DDW Satellite Symposia and Marketing Opportunities will be billed at 100% upon selection and execution of the application and sponsorship contracts.  Payment is due no later than 30 days from the date of order.  Failure to make full payment by this date will result in the item being placed back into inventory for another party to purchase and Satellite Symposia organizers will incur cancellation fees for the Satellite Symposia fee (see below).  All payments are non-refundable after Jan. 21, 2023. DDW reserves the right to reject or resell any opportunity if payment is not received within 30 days. If an order is placed after Jan. 31, 2023, payment will be due upon reservation. DDW reserves the right to not fulfill any unpaid Marketing Opportunities. Space will be assigned only after full payment has been received based on availability at that time.

Cancellation Fee 

Notification of satellite symposium must be in writing. Any supporter canceling a satellite symposium will be charged a fee based on the following schedule:   

  • On or before Feb. 14, 2023: 50% of total fee is due, regardless of whether the slot is re-sold.  
  • After Feb. 14, 2023: 100% of total fee is due, regardless of whether the slot is re-sold. 

Satellite Symposium cancellations will result in automatic cancellation of any marketing opportunities and registered staff secured for the satellite symposium. No refunds will be provided for these other opportunities. 

FAQs

Approximately 10,000 attendees for both in-person and the virtual platform.

DDW does not guarantee attendance. Attendance heavily depends on your topic; however, date and time may have some impact based on conflicting priorities. Attendance is primarily driven by pre-show marketing efforts and tactics deployed by sponsoring organizations. Based on historical data, a.m. symposia can average anywhere between 150-350 attendees, and p.m. symposia average anywhere from 200-500 attendees. DDW does not track audience demographics at symposia. These estimates are from pre-COVID DDWs.

Yes, but we won't coordinate any of the details, and you would be required to do so yourself. We also won't provide the virtual platform for it. Please reach out to Cheryl-Butler Poole for more information.

No. You must provide or independently obtain the CME or CE certification for your activity.

No.

DDW has no involvement in the content of the actual event, but we must review and approve all copy for invitations and flyers sent to DDW attendees.

DDW allows partners to post their presentations online if the presentation does not make mention of DDW. Presentations must be hosted by the education partner. DDW will post a link to the education partner's website on the Satellite Symposia Schedule page for attendees to view post show. Links will be posted until Aug. 31, 2023.

Yes, however it is the sponsor's responsibility to collect any contact information during the symposium and to acquire all the permissions to contact each attendee. DDW cannot provide attendee contact information. All promotional materials for live streaming presentations or hosting presentations online must follow DDW's rules and regulations, and must be reviewed and approved by DDW prior to release.

The following schedule is as of May 11, 2022. Please use the DDW Mobile App or DDW Online Planner for final times and locations.

Saturday, May 21, 2022

6:15 a.m.Optimizing Care in Inflammatory Bowel Disease (IBD): The Role of Emerging Therapies in Improving Patient Outcomes
Supported by AbbVie
Provided by Physicians' Education Resource
Registration: 5:45–6:15 a.m.
Symposium and Breakfast: 6:15–7:45 a.m.
Location: Hilton San Diego Bayfront, (Sapphire IJMN)
CME: 1.5 AMA PRA Category 1 credits
The satellite is an activity that has the aim of educating clinicians on the latest advances impacting patient care in IBD. This satellite will provide attendees with an opportunity to interact and engage with experts on IBD, gaining insight from their experiences and perspective along the continuum of care.
6 p.m.Patient-Centered Management of Ulcerative Colitis: The Urgent Patient Need
Supported by Lilly
Provided by Medscape
Registration: 6–6:30 p.m.
Symposium and Dinner: 6:30–7:30 p.m.
Location: Marriott Marquis San Diego (Marina Ballroom F)
CME: 1.0 AMA PRA Category 1 Credits
The impact of ulcerative colitis (UC) on patients’ quality of life cannot be overstated. However, quality of life is sometimes overlooked in practice as clinicians are often focused primarily on improvement of clinical measures and treatment goals. At this symposium, a person with UC will join our panel to share their experience in living with the disease and the impact of bowel urgency on daily life. Our faculty presenters will provide their expert perspectives regarding the prevalence and impact of urgency on patient quality of life, as well as best practices how to incorporate bowel urgency into a patient-centered treatment plan. Register here.
Perspectives and Updates in Managing H pylori Infection 
Supported by Phathom Pharmaceuticals
Provided by Medscape
Registration: 6–6:30 p.m.
Symposium and Dinner: 6:30–8 p.m.
Location: Marriott Marquis San Diego (Marina Ballroom G)
CME: 1.5 AMA PRA Category 1 credits
 Strategies for Addressing Treatment Challenges and Health Inequities in IBD
Supported by Janssen Biotech, Inc.
Provided by Clinical Care Options, LLC
Registration: 6–6:30 p.m.
Symposium and Dinner: 6:30–8 p.m.
Location: Hilton San Diego (Sapphire Ballroom IJMN)
CME: 1.5 AMA PRA Category 1 credits
Chair: Anita Afzali, MD, MPH, FACG, Prof of Medicine, Medical Director, The Ohio State University Wexner Medical Center
Speakers: David P. Hudesman, MD, FACG, AGAF, Associate Professor of Medicine, Co-Director IBD Center, University of North Carolina at Chapel Hill
Millie D. Long, MD, MPH, Professor of Medicine, Director, Vice-Chief, University of North Carolina at Chapel Hill
Inflammatory bowel disease (IBD) can cause significant physical burden while also negatively affecting quality of life, relationships, and work/school productivity. To alleviate this burden, clinicians must be familiar with the latest research findings, best practices, and therapy advances and be well-equipped to individualize care, including pregnancy/family planning, therapeutic drug monitoring, a treat-to-target approach, and shared decision making. Understanding health disparities and how to reduce their impact on patients is equally critical to optimal IBD management. As such, clinicians who treat patients with IBD must be equipped with the latest evidence to provide the best possible care for their patients. Register here.
Let's Smash NASH!
Supported by Novo Nordisk
Provided by AGA
Registration: 6–6:30 p.m.
Symposium and Dinner: 6:30–8 p.m.
Location: Hilton San Diego (Sapphire Ballroom CDGH)
CME: 1.5 AMA PRA Category 1 credits
Chair: Fasiha Kanwal, MD, MSHS, Professor of Medicine and Chief of Gastroenterology, Baylor College of Medicine
Speakers: Jay Shubrook, MD,Director of Clinical Research and Diabetes Service, Touro University
AGA's Let’s Smash NASH! program features six speakers in gastroenterology, endocrinology, and primary care and will fill the educational gaps on the link between metabolic syndrome and NAFLD/NASH and current clinical guidance on screening, diagnosis, and management of patients with type 2 diabetes and obesity who are at high risk of NAFLD/NASH. All educational materials will reflect the current science and will be designed to address the specific needs of clinicians who manage patients with NAFLD and NASH.
A Practitioner’s Guide to Hepatobiliary Carcinoma: Immunotherapy Edition
Supported by AstraZeneca
Provided by Medscape Education
Registration: 6–6:30 p.m.
Symposium and Dinner: 6:30–8 p.m.
Location: Manchester Grand Hyatt (Harbor AB)
CME: 1.5 AMA PRA Category 1 credits
The goal of this interactive live and virtual symposium is to provide practical education to gastroenterologists, oncologists, and other clinicians involved in the care of patients at risk of or diagnosed with hepatobiliary cancers to enable the integration of diagnostic standards, emerging therapies, and multidisciplinary care into their daily practices. 
Advances in the Treatment of Diabetic Gastroparesis
Supported by Evoke Pharma
Registration: 6–6:30 p.m.
Symposium and Dinner: 6:30–8:30 p.m.
Location: Manchester Grand Hyatt (Harbor GH)
Speaker: Richard W. McCallum, MD, Professor and Founding Chair, Department of Internal Medicine, Texas Tech University
Explore the burden of DGP, unmet treatment need and the role of GIMOTI nasal spray in the treatment paradigm. Discuss potential benefits of the nasal route of administration and the challenge of treating DGP patients with oral meds.

Sunday, May 22, 2022

6 a.m.Rare, Overlooked, and Underappreciated Causes of Recurrent Abdominal Pain
Location: Hilton San Diego Bayfront (Sapphire IJMN)
Recurrent abdominal pain is a common reason for repeated visits to outpatient clinics and emergency departments, reflecting a substantial unmet need for timely and accurate diagnosis. A lack of awareness of some of the rarer causes of recurrent abdominal pain may impede diagnosis and delay effective management. This panel discussion focuses on some of the key rare but diagnosable causes that are frequently missed by gastroenterologists, and provides expert recommendations to support recognition, diagnosis, and management with the ultimate aim of improving patient outcomes.
6:15 a.m.New Directions for the Treatment of Ulcerative Colitis: Evidence and Guidance For Incorporating S1P Receptor Modulators into Practice
Supported by Bristol Myers Squibb
Provided by Answers in CME
Registration: 6:15–6:45 a.m.
Symposium and breakfast: 6:45–7:45 a.m.
Location: Omni San Diego (Grand Ballroom Salons CDE)
CME: 1 AMA PRA Category 1 credit
This session will focus on the evolving role of sphingosine-1-phosphate (S1P) receptor modulators for the treatment of patients with moderately to severely active ulcerative colitis (UC). Dr. Marla C. Dubinsky and Dr. Bruce E. Sands will highlight how the S1P receptor modulators target the disease pathology, evaluate the clinical data on newly approved and emerging S1P receptor modulators, and identify evidence-based, patient-centered strategies to optimally utilize these agents in practice. This activity is supported through an educational grant from Bristol Myers Squibb.
6 p.m.Patient-Centered Thinking & Achieving Optimal Outcomes in Patients with UC
Supported by Takeda
Provided by RMEI Medical Education, LLC
Location: Marriott Marquis San Diego (Marina Ballroom B)
CME: 1.5 AMA PRA Category 1 credits
This symposium will feature a multidisciplinary team and experienced ulcerative colitis (UC) patient. It will highlight challenges in UC care from an inter-professional team perspective, and address a treat-to-target approach, selection of biologics, clinical decision support tools, and shared-decision making for optimal outcomes in UC.
Improving Outcomes in Pediatric and Adult Patients with Eosinophilic Esophagitis Through Earlier Diagnosis and Treatment
Supported by Regeneron Pharmaceuticals Inc. and Sanofi Genzyme
Provided by the Med Learning Group
Registration: 6–6:30 p.m.
Symposium and dinner: 6:30–7:30 p.m.
Location: Hilton San Diego (Sapphire Ballroom ABEF)
CME: 1 AMA PRA Category 1 credit
This case-based live activity will focus on the epidemiology, pathophysiology, diagnosis, and treatment of eosinophilic esophagitis. Patients with EoE are often diagnosed after symptom onset, leading to greater chronic inflammation, and treatment plans are frequently not tailored to individual needs. This activity is intended to help healthcare providers diagnose EoE earlier and provide individualized treatment based on guidelines, recent clinical data and patient characteristics. Register here.
Opening the Window of Opportunity in Treating Crohn’s Disease
Supported by Takeda Pharmaceuticals, U.S.A., Inc.
Provided by Medscape
Registration: 6–6:30 p.m.
Symposium and dinner: 6:30–8 p.m.
Location: Marriott Marquis San Diego (Marina Ballroom G)
CME: 1.5 AMA PRA Category 1 credits
While treatment of Crohn’s Disease is not one-size-fits-all, aggressive early treatment is the best choice for many patients to prevent irreversible long-term consequences. However, there are multiple barriers that prevent intervention during this crucial window of opportunity, including a lack of consistent risk stratification, outdated clinical guidelines and evolving treat-to-target best practices. Join our DDW 2022 case-based symposium to hear both expert and patient perspectives on treatment selection and shared decision-making to improve both short- and long-term life with Crohn’s Disease. Register here.
Recurrent Clostridioides difficile: Advancing the Science of Microbiome-Directed Therapeutics 
Supported by Seres Therapeutics, Inc and Aimmune Therapeutics
Provided by Medscape
Registration: 6–6:30 p.m.
Symposium and dinner: 6:30–8 p.m.
Location: Marriott Marquis San Diego (Marina Ballroom G)
Chair: Carl V. Crawford, MD, Assistant Professor of Clinical Medicine, Weill Cornell Medicine
Speakers: Paul Feuerstadt, MD, Assistant Clinical Professor of Medicine, Yale University School of Medicine
Monika Fischer, MD, MS, Associate Professor of Medicine, Indiana School of Medicine, Sahil Khanna, MBBS, MS, Professor of Medicine, Mayo Clinic
CME: 1.5 AMA PRA Category 1 credits
Keeping Things Moving in the Treatment of Chronic Idiopathic Constipation: Exploring the Evidence and Guidelines Through Case Studies
Supported by Novo Nordisk, Inc.
Provided by CME Outfitters, LLC
Registration: 6–6:30 p.m.
Symposium and dinner: 6:30–8 p.m.
Location: Hilton San Diego Bayfront (Sapphire Ballroom, IJ)
CME: 1.5 ACCME ANCC ACPE ABIM MOC II
The symposium will feature expert faculty and case-based discussion on accurate diagnosis of chronic idiopathic constipation, characteristics of therapy, and developing a comprehensive treatment strategy based on evidence and clinical guidelines.
Optimizing the Treatment of Irritable Bowel Syndrome: The Patient With IBS-C
Supported by Ardelyx
Provided by Medscape Education
Registration: 6–6:30 p.m.
Symposium and dinner: 6:30–7:30 p.m.
Location: Hilton San Diego Bayfront (Sapphire Ballroom, MN)
CME: 1 AMA PRA Category 1 credit
New and Emerging Small Molecules: Making a Difference in UC
Location: Manchester Grand Hyatt (Harbor AB)
This activity will cover the differentiation of oral small molecules currently available and under investigation for the treatment of ulcerative colitis, including their mechanisms of action, pharmacokinetics, and clinical efficacy and safety.

Monday, May 23, 2022

6 p.m. The Erosive Esophagitis Expert Exchange
Supported by Phathom Pharmaceuticals
Provided by Medscape Education
Registration: 6–6:30 p.m.
Symposium and dinner: 6:30–7:30 p.m.
Location: Marriott Marquis San Diego (Marina Ballroom F)
CME: 1 AMA PRA Category 1 credit
Gastroesophageal reflux disease (GERD) is a chronic, highly prevalent gastrointestinal disorder. A serious manifestation of untreated GERD is erosive esophagitis (EE), which is characterized by erosions or ulcers in the esophageal mucosa. Proton pump inhibitors are the mainstay of treatment of GERD and EE; however, some patients do not have an adequate response to these drugs and disease recurrence is common. In this live, interactive symposium, expert faculty will guideline-based treatment of GERD/EE and review emerging therapies.
Syndromic Testing for Gastroenteritis:   The Importance of Timely Pathogen Identification 
Supported by Biomerieux
Provided by Medscape Education
Registration: 6–6:30 p.m.
Symposium and dinner: 6:30–8 p.m.
Location: Marriott Marquis San Diego (Marina Ballroom F)
CME: 1.5 AMA PRA Category 1 credits
In the US.., where more than half of the adult population has at least one common chronic condition, about 48 million people contract a foodborne illness every year. In addition, infectious gastroenteritis (due to viruses, bacteria, or parasites) is associated with about 1.6 million deaths annually across the globe. Rapid diagnostic methodologies for pathogen identification represent a tremendous advancement over traditional culture-based methods regarding the ability to quickly identify a causative pathogen and initiate appropriate antibiotics in a timely manner. In this live CME event, syndromic panel and gastrointestinal experts will discuss the role of syndromic testing in the diagnosis of gastroenteritis.
Elevating Ulcerative Colitis Treatment Expectations - Time to Expect More? 
Supported by Eli Lilly and Company
Registration: 6–6:15 p.m.
Symposium and dinner: 6:30–7:30 p.m.
Location: Omni San Diego Hotel (Grand Ballroom)
Chair: David T. Rubin , MD, AGAF, Joseph B. Kirsner Professor of Medicine, University of Chicago
Speakers: Marla C. Dubinsky, MD, Professor of Pediatrics and Medicine, Mount Sinai Kravis Children’s Hospital, New York
Simon Travis, MD,DPhil, FRCP, Professor, University of Oxford, John Radcliffe Hospital, Oxford, UK
In this interactive symposium, evolving definitions and treatment targets in ulcerative colitis will be reviewed and discussed. The importance of bowel urgency remission in ulcerative colitis will be examined, and the value of histological remission will be explored. New and emerging concepts of remission and treatment targets will be proposed, with the goal of improved patient outcomes.
Dr. Victor Fazio IBD Symposium: Innovations in Medical and Surgical Therapies for Inflammatory Bowel Disease
Supported by Cleveland Clinic, Digestive Disease & Surgery Institute
Registration: 6–6:30 p.m.
Symposium and dinner: 6:30–8:45 p.m.
Location: Hilton San Diego Bayfront, (Sapphire Ballroom IJMN)
Chair: Miguel Regueiro, MD, AGAF, FACG, Chair, Digestive Disease and Surgery Institute, Cleveland Clinic
Speakers: Neil Hyman, MD, Professor of Surgery and Chief, Colorectal Surgery, University of Chicago
Millie D. Long, MD, MPH, Professor of Medicine, Division of GI-Hepatology, University of North Carolina
Benjamin Cohen, MD, Co-Section Head and Clinical Director for IBD, Cleveland Clinic
Tracy Hull, MD, Professor of Surgery, Lerner College of Medicine, Cleveland Clinic, Cleveland Clinic
Faculty - Digestive Disease & Surgery Institute: Amy Lightner, MD, Jessica Philpott, MD, Scott R. Steele, MD.
This satellite symposium will offer in-depth perspectives on the changing thoughts of surgery for IBD patients. Also featured will be the risks and benefits of biologic and small molecule therapies for improved outcomes, along with expert panel discussions that includes the management of medical-surgical IBD cases. Please note an RSVP is required for a plated meal. Register here.
The Microbiome and Recurrent C. Difficile: Trust your Gut
Supported by Ferring Pharmaceuticals Inc.
Provided by Medscape
Registration: 6–6:30 p.m.
Symposium and dinner: 6:30–8 p.m.
Location: Marriott Marquis San Diego (San Diego Ballroom B)
CME: 1.5 AMA PRA Category 1 credits

Related Opportunities

Product Theater

Product Theaters are turnkey, 45-minute marketing presentations about your company’s products or services.

ICWs are meetings and events arranged by exhibitors, third party planners, educational institutions or other non-profit organizations during DDW.

In-Conjunction With Meetings

ICWs are meetings and events arranged by exhibitors, third-party planners, educational institutions or other non-profit organizations during DDW.

Industry Supporter Prospectus

The prospectus provides details you need to know to reserve your space at DDW 2023.